KK

Cytokinetics IncDUS Cytokinetics Stock Report

Last reporting period 30 Sep, 2024

Updated 25 Nov, 2024

Last price

Market cap $B

6.196

Middle

Exchange

XDUS - Boerse Duesseldorf

View Section: Company Analysis

Cytokinetics Rating

KK

KK3A.DU stock rating score is -54/100. Cytokinetics is aExtremely Risky Investment.

The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.

Eyestock Rating

Last update 12.11.2024

-54/100

Low score

Rating Breakdown

  • Profitability score

    -25

    /25

  • Solvency score

    -2

    /25

  • Efficiency score

    -25

    /25

  • Stability score

    -2

    /25

Cytokinetics Inc Rewards and Warnings

The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.

Financial

Check

Value

Net Profit Margin

-17906 %

Earnings quality

Gross Margin

Cytokinetics Inc's Historical Rating

How has the company's valuation changed in the past?

A quick analysis will help you understand how stable financial indicators are overall.


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Discover High-rated Companies


View Section: Valuation